Novel pain therapy system manages patients with chronic neuropathic pain21 May 2013 A study investigating the safety and performance of Spinal Modulation Inc's Axium Spinal Cord Stimulator (SCS) System has shown that after 6 months of treatment 70% of patients suffering from leg pain and 89% of patients suffering from foot pain reported clinically significant pain relief. [1] The Axium Spinal Cord Stimulator (SCS) System is aimed at relieving chronic pain experienced by patients suffering from long-term nerve damage following surgery (chronic post surgical pain), complex regional pain syndrome (CRPS), amputation pain, or failed back surgery syndrome (FBSS). Chronic post surgical pain is caused by nerve damage resulting from a surgical procedure, for example inguinal hernia repair. If nerves are damaged during surgery some patients may develop long-term neuropathic pain. The number of people suffering from neuropathic pain and chronic post surgical pain is not well documented. However, it is estimated that 30-50% of patients after amputation, 20-30% of women after mastectomy or lumpectomy, and 10% of patients after inguinal hernia repair suffer from chronic post surgical pain. “Instead of stimulating the back of the spinal cord, we can now
stimulate important branches of the spinal cord, the Dorsal Root
Ganglia (DRG). This small move laterally from the spinal cord to the Key results of the study published in include:
"In my experience this novel approach to chronic pain management
offers an important new option for patients suffering from chronic
neuropathic pain. The Axium SCS System is associated with References 1. Liong L et al. A multicenter, prospective trial to
assess the safety and performance of the spinal modulation dorsal
root ganglion neurostimulator system in the treatment of chronic
pain. Neuromodulation: Technology at the Neural Interface.
Article first published online: 13 May 2013 DOI: 10.1111/ner.12072
|
|||